Literature DB >> 7757283

An in vitro model for abnormal skeletal development in the lysosomal storage diseases.

A L Aulthouse1, J Alroy.   

Abstract

Lysosomal storage diseases such as GM1-gangliosidosis are associated with skeletal abnormalities. Radiological and histological studies, both in human and corresponding animal models, indicate retarded bone formation. Since cartilage maturation leads to bone formation, we developed an in vitro system to study and compare the biological features of cartilage from dogs affected with GM1-gangliosidosis with age-matched controls. Costochondral chondrocytes were grown in monolayer and in agarose culture. Both affected and control cells dedifferentiated in monolayer; however, in agarose culture they re-expressed the chondrocytic phenotype. Cells from affected dogs were enlarged and contained numerous large vacuoles when compared with control cells. This morphology was similar to that seen in vivo. In addition, the affected cells appeared to have a reduction in mitosis and alcian blue staining proteoglycans. Cultures from affected animals contained fewer cells positive for alkaline phosphatase activity. Both affected and control cells expressed collagen types I and II and were positive for the lectin Ricinus communis agglutinin-I. However, the staining of the control culture for type II collagen was more prominent than in the affected cells. These findings suggest that culture of chondrocytes in agarose may be a useful method for studying the biology of cartilage which leads to skeletal abnormalities in lysosomal storage diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7757283     DOI: 10.1007/BF00192634

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  17 in total

1.  Expression of the human chondrocyte phenotype in vitro.

Authors:  A L Aulthouse; M Beck; E Griffey; J Sanford; K Arden; M A Machado; W A Horton
Journal:  In Vitro Cell Dev Biol       Date:  1989-07

2.  Histological and histochemical uses of periodic acid.

Authors:  J F A McMANUS
Journal:  Stain Technol       Date:  1948-07

3.  A monoclonal antibody specific for the amino terminal cleavage site of procollagen type I.

Authors:  H G Foellmer; K Kawahara; J A Madri; H Furthmayr; R Timpl; L Tuderman
Journal:  Eur J Biochem       Date:  1983-07-15

4.  The biochemical basis of gangliosidoses.

Authors:  K Sandhoff; E Conzelmann
Journal:  Neuropediatrics       Date:  1984-09       Impact factor: 1.947

5.  Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels.

Authors:  P D Benya; J D Shaffer
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

6.  Retarded bone formation in GM1-gangliosidosis: a study of the infantile form and comparison with two canine models.

Authors:  J Alroy; K Knowles; S H Schelling; E M Kaye; A E Rosenberg
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Canine GM1-gangliosidosis. A clinical, morphologic, histochemical, and biochemical comparison of two different models.

Authors:  J Alroy; U Orgad; R DeGasperi; R Richard; C D Warren; K Knowles; J G Thalhammer; S S Raghavan
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

8.  Influence of retinol on human chondrocytes in agarose culture.

Authors:  A L Aulthouse; C M Carubelli; T M Dow; C Ziegelmayer; M Beck
Journal:  Anat Rec       Date:  1992-01

Review 9.  The teratogenic effects of valproic acid in human chondrogenesis in vitro.

Authors:  A L Aulthouse; D C Hitt
Journal:  Teratology       Date:  1994-03

10.  Effects of ascorbic acid on collagen mRNA levels in short term chondrocyte cultures.

Authors:  L J Sandell; J C Daniel
Journal:  Connect Tissue Res       Date:  1988       Impact factor: 3.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.